ELEVAR Trademark

Trademark Overview

On Monday, August 14, 2023, a trademark application was filed for ELEVAR with the United States Patent and Trademark Office. The USPTO has given the ELEVAR trademark a serial number of 98132272. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Monday, February 23, 2026. This trademark is owned by Elevar Therapeutics, Inc.. The ELEVAR trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, experimental and novel cancer therapeutics
elevar

General Information

Serial Number98132272
Word MarkELEVAR
Filing DateMonday, August 14, 2023
Status733 - FOURTH EXTENSION - GRANTED
Status DateMonday, February 23, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, experimental and novel cancer therapeutics
Translation of Words in MarkThe English translation of ELEVAR in the mark is to raise.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, September 13, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameElevar Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Lee, NJ 07024
US
Party NameElevar Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84121
US

Trademark Events

Event DateEvent Description
Thursday, August 17, 2023NEW APPLICATION ENTERED
Wednesday, September 13, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 8, 2024ASSIGNED TO EXAMINER
Friday, February 9, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 15, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, October 15, 2024SOU EXTENSION 1 FILED
Tuesday, October 15, 2024SOU EXTENSION 1 GRANTED
Monday, October 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 12, 2025SOU TEAS EXTENSION RECEIVED
Monday, May 12, 2025SOU EXTENSION 2 FILED
Tuesday, May 13, 2025SOU EXTENSION 2 GRANTED
Tuesday, May 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 31, 2025SOU TEAS EXTENSION RECEIVED
Friday, October 31, 2025SOU EXTENSION 3 FILED
Friday, October 31, 2025SOU EXTENSION 3 GRANTED
Friday, October 31, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 23, 2026SOU TEAS EXTENSION RECEIVED
Monday, February 23, 2026SOU EXTENSION 4 FILED
Monday, February 23, 2026SOU EXTENSION 4 GRANTED
Tuesday, February 24, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

elevar cancer therapeutics novel experimental preparations namely pharmaceutical